Quick Answer
KIORA PHARMACEUTICALS INC reported Stockholders Equity of $16.13 million for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed a decrease of -37.4% in Stockholders Equity from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $913.7 thousand | Q3 2015: $8.68 million | Q1 2016: $6.67 million | Q2 2016: $6.47 million | Q3 2016: $3.25 million | Q1 2017: -$1.15 million | Q2 2017: $4.57 million | Q3 2017: $679.4 thousand | Q1 2018: $5.28 million | Q2 2018: $13.55 million | Q3 2018: $11.10 million | Q1 2019: $10.04 million | Q2 2019: $8.47 million | Q3 2019: $5.21 million | Q1 2020: $9.32 million | Q2 2020: $7.80 million | Q3 2020: $5.96 million | Q1 2021: $15.99 million | Q2 2021: $13.68 million | Q3 2021: $20.51 million | Q1 2022: $11.26 million | Q2 2022: $8.76 million | Q3 2022: $10.52 million | Q1 2023: $10.16 million | Q2 2023: $13.64 million | Q3 2023: $8.10 million | Q1 2024: $34.90 million | Q2 2024: $33.10 million | Q3 2024: $30.03 million | Q1 2025: $23.70 million | Q2 2025: $22.13 million | Q3 2025: $22.41 million.
- Over the full 12 years of available data (2014 to 2025), KIORA PHARMACEUTICALS INC's Stockholders Equity has grown by 134.5%.
- Historical annual values: Fiscal year 2025: $16.13 million | Fiscal year 2024: $25.76 million | Fiscal year 2023: $6.11 million | Fiscal year 2022: $11.41 million | Fiscal year 2021: $14.58 million | Fiscal year 2020: $9.73 million | Fiscal year 2019: $6.62 million | Fiscal year 2018: $8.94 million | Fiscal year 2017: -$1.93 million | Fiscal year 2016: -$329.4 thousand | Fiscal year 2015: $6.09 million | Fiscal year 2014: -$46.81 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: